Biotech Weekly Ending 8/18 …Five Day Performance
The Biotech sector held on a turbulent geopolitical week favoring large caps. Amgen (AMGN) up 1.7%, Merck (MRK) up 3.6%, Regeneron (REGN) up 2.1%. Gilead Sciences (GILD) was off 6% on concerns it would lose market share of its HIV drug to GlaxoSmith Kline (GSK) up 2.9% for the week.
FBT down 0.6% to $149.76, IBB down 0.8% to $116.29, QQQ down 0.6% to $179.86
XBI down 1.1% to $93.96, XLV up 1.2% to $91.11 near January 2018 highs.
Aug 16 YoYo Market Rallies on Solid Earnings, Trade talks with China, Dow up 1.58%
- Booming Walmart and Cisco Sales shows economy strength
- Stocks and emerging market currencies rise on trade talks with China
- FBT up 1.02%, IBB up 0.77%, XBI up 0.9%, XLV up 0.97% : MRK REGN leading large caps; Gene Editing stocks strong CRSP EDIT NTLA
Aug 15 Risk off on Turkey Turmoil,Emerging Market Woes
All major indices down >1% despite strong US economic data on retail sales and industrial production.
Commodities, materials and energy sector sell-off. Trade worries weigh. Dollar strong.
Biotechs sell-off on macro news IBB down 1.45%, XBI down 1.72%.
Aug 14 Biotech stocks mainly green
FBT up 0.77%,IBB up 0.56%,XBI up 0.41%, XLV up 0.47%
Hold Trading Range
We are on vacation this week and will post articles only with major market moves or news. with all the global macro news dominating the market it may be best to hold and limit trading.